A Partial Randomized, Single-blind or Open-label, Dose-escalation With Multiple-dose Design Study to Evaluate the Pharmacokinetics of Acetaminophen and Its Toxic Metabolites With Panadol ® and Various Formulations of SafeTynadol® in Healthy Volunteers
Conditions: Hepatitis; Pharmacology Interventions: Drug: Panadol; Drug: SafeTynadol® Sponsor: Sinew Pharma Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acetaminophen | Drugs & Pharmacology | Eyes | Hepatitis | Hepatitis A | Lortab | Research | Study | Toxicology